< Back
Beneficiary

Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto)

Porto,
Portugal

The Portuguese Oncology Institute of Porto (IPO Porto) is a highly differentiated organisation belonging to the National Health System and providing specialised care. IPO Porto is a national and international reference health institution in oncological treatment, research and education. IPO PORTO is accredited as a Comprehensicve Cancer Center by the European Organization of Cancer Institutes (OECI).

IPO PORTO is involved in serveral project activities, including WP 1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Key People Involved:

Julio Oliveira

MD, Medical Oncologist and Clinical Pharmacologist, President of the board of IPO-Porto

Professor Henrique Rui

MD PhD, Pathologist, Director of Pathology Department of IPO Porto

Beatrice Mainoli

MD, Clinical Pharmacologist, Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto)

Joana Assis

PhD, Clinical Research Coordinator, Early Phase Clinical Trial Unit, IPO Porto

partners

Beneficiaries & Associated Partners

Associated Partner

Masaryk Memorial Cancer Institute (MMCI)

Brno,
Czech Republic

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Associated Partner

Center for Personalized Cancer Treatment hosted by Radboud University Medical Center

Nijmegen,
Netherlands

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Associated Partner

Region Skåne

Skåne,
Sweden

Participation in WP1 (data aggregation) and WP3 (expansion cohorts).

Learn more >